Toxicities associated with hyperthermic isolated limb perfusion and isolated limb infusion in the treatment of melanoma and sarcoma

By Moller Mecker   Lewis James   Dessureault Sophie   Zager Jonathan  

International Journal of Hyperthermia, Vol. 24, Iss. 3, 2008-01 ,pp. : 275-289

Informa Healthcare

Access to resources Recommend Favorite

Current status of hyperthermic limb perfusion for in-transit melanoma

By I. Ross Merrick  

International Journal of Hyperthermia, Vol. 24, Iss. 3, 2008-01 ,pp. : 205-217

Informa Healthcare

Access to resources Recommend Favorite

Isolated limb perfusion for malignant melanoma; possibly better results with high dose hyperthermia

By  

International Journal of Hyperthermia, Vol. 24, Iss. 7, 2008-01 ,pp. : 602-603

Informa Healthcare

Access to resources Recommend Favorite

A Phase II Trial of Isolated Limb Infusion With Melphalan and Dactinomycin for Regional Melanoma and Soft Tissue Sarcoma of the Extremity

By Brady Mary   Brown Karen   Patel Ami   Fisher Charles   Marx Will  

Annals of Surgical Oncology, Vol. 13, Iss. 8, 2006-08 ,pp. : 1123-1129

Springer Publishing Company

Access to resources Recommend Favorite

Does Increased Experience with Isolated Limb Infusion for Advanced Limb Melanoma Influence Outcome? A Comparison of Two Treatment Periods at a Single Institution

By Huismans Anna  

Annals of Surgical Oncology, Vol. 18, Iss. 7, 2011-07 ,pp. : 1877-1883

Springer Publishing Company

Access to resources Recommend Favorite